← back to search

Deanna Saylor

University of North Carolina at Chapel Hill · US
Area of research
Emergency Medicine · Virology
Research interest
Research interests include HIV-related health complications and treatments, HIV Research and Treatment, Acute Ischemic Stroke Management, and HIV/AIDS Research and Interventions.
h-index
28
citations
4,211
works
243
NIH funding
primary concept
email

Recent publications

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
The Lancet Neurology 2025cited by 254position: middledoi
Longitudinal Trends in Physical Activity Among Older Adults With and Without HIV in Uganda
Journal of Aging and Health 2025cited by 2position: middledoi
National plans and awareness campaigns as priorities for achieving global brain health
The Lancet Global Health 2024cited by 30position: middledoi
Differential diagnosis of suspected multiple sclerosis: global health considerations
The Lancet Neurology 2024cited by 27position: middledoi
Reply to ‘Cognitive criteria in HIV: greater consensus is needed’
Nature Reviews Neurology 2024cited by 4position: middledoi
Prevalence and Correlates of Frailty Among Older People With and Without HIV in Rural Uganda
JAIDS Journal of Acquired Immune Deficiency Syndromes 2024cited by 2position: middledoi
Cognitive impairment in people living with HIV: consensus recommendations for a new approach
Nature Reviews Neurology 2023cited by 146position: middledoi
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis
Frontiers in Neurology 2023cited by 20position: middledoi
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
Journal of the Neurological Sciences 2023cited by 15position: middledoi
Diagnosis and classification of optic neuritis
The Lancet Neurology 2022cited by 288position: middledoi
Priorities for health and wellbeing for older people with and without HIV in Uganda: a qualitative methods study
Journal of the International AIDS Society 2022cited by 16position: middledoi
The benefits of care: treated HIV infection and health-related quality of life among older-aged people in Uganda
Aging & Mental Health 2022cited by 10position: middledoi
Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
The Journal of Headache and Pain 2021cited by 66position: middledoi
The Global Burden of Headache
Seminars in Neurology 2018cited by 328position: lastdoi
HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
Nature Reviews Neurology 2016cited by 1,036position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Noeline Nakasujja · University Hospitals of Cleveland5 papers (2022–2024)Stephen Asiimwe · University of California System3 papers (2022–2024)Zahra Reynolds · Harvard University3 papers (2022–2024)Alexander C. Tsai · San Francisco General Hospital3 papers (2022–2024) · 3 papers (2022–2024)Mark J. Siedner · Harvard University3 papers (2022–2024)Brianne Oliveri-Mui · Northeastern University3 papers (2022–2024)Meredith Greene · University of California, San Francisco3 papers (2022–2024)Christine S. Ritchie · Massachusetts General Hospital2 papers (2022–2024)Anna J. Dreyer · University of Cape Town2 papers (2023–2024)John A. Joska · University of Cape Town2 papers (2023–2024)Richard W. Price · San Francisco General Hospital2 papers (2023–2024)Robert Paul · Brown University2 papers (2022–2024)Janet Seeley · London School of Hygiene & Tropical Medicine2 papers (2022–2022)Jonathan Underwood · Cardiff and Vale University Health Board2 papers (2023–2024)Paola Cinque · Vita-Salute San Raffaele University2 papers (2023–2024) · 2 papers (2022–2024)Richard Pebody · London School of Hygiene & Tropical Medicine2 papers (2023–2024)Yao Tong · Wenzhou Medical University2 papers (2022–2024)Kevin G. F. Thomas · University of Fribourg2 papers (2023–2024)